On the 5th and 6th of March, Barcelona hosted XI Annual Conference of Biomedical Research Technology Platforms. Different advances in Innovative Medicines, Nanomedicine, Health Technology and Biotechnology Markets were presented. The focus was on the use of these advances and their necessary coexistence with the legal framework of clinical research and data protection.

Synapse CEO, Carlos Díaz participated in a debate on how to share data in biomedical research. The session was focused on the experience acquired in the IMI Big Data for Better Outcomes (BD4BO) initiative including representatives from the ROADMAP and HARMONY (both managed by Synapse), BigData@Heart and DO-IT projects.

Carlos Díaz presented the ROADMAP project, that provides the foundation for an integrated data environment and framework for real-world evidence (RWE) in Alzheimer’s disease, highlighting its main pillars and challenges. It was a great pleasure to present ROADMAP at the event alongside most other projects in the BD4BO programme – who all counted on Spanish representation. Good and interesting session allowing us to build bridges with our BD4BO colleagues, and understand better the new legal framework in Europe in terms of data protection.

More about ROADMAP at https://roadmap-alzheimer.org/.

More about HARMONY at https://www.harmony-alliance.eu/.

More about BD4BO at http://bd4bo.eu/.